Stoke Therapeutics (STOK) Interest Coverage Ratio (QoQ) (2020 - 2026)
Stoke Therapeutics (STOK) Interest Coverage Ratio (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Stoke Therapeutics | 1.87 Bn | 1.53 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,035.55% |
| Dec 31, 2025 | 99.61% |
| Sep 30, 2025 | -306,482.73% |
| Jun 30, 2025 | -100.00% |
| Mar 31, 2025 | 629,914.11% |
| Jun 30, 2024 | -355.04% |
| Mar 31, 2024 | -580,973.02% |
| Dec 31, 2023 | 99.86% |
| Sep 30, 2023 | -1,827.45% |
| Jun 30, 2023 | 80.10% |
| Mar 31, 2023 | -14,773.63% |
| Dec 31, 2022 | 98.26% |
| Sep 30, 2022 | -301.47% |
| Jun 30, 2022 | 89.05% |
| Mar 31, 2022 | -9,504.34% |
| Dec 31, 2021 | 95.66% |
| Sep 30, 2021 | 79.79% |
| Jun 30, 2021 | 94.63% |
| Mar 31, 2021 | -319.74% |
| Dec 31, 2020 | 254.25% |